ARQT

Arcutis Biotherapeutics News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Arcutis Biotherapeutics Inc ARQT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
1.10 4.43% 25.94 14:35:05
Open Price Low Price High Price Close Price Previous Close
24.63 24.63 26.475 24.84
more quote information »

Recent News

Date Time Source Heading
12/01/202016:05GLOBEData from Long-Term Safety Study Support Chronic Use of..
11/23/202007:30GLOBEArcutis Announces Positive Topline Data from Phase 2b Study..
11/13/202011:57EDGARStatement of Changes in Beneficial Ownership (4)
11/11/202016:05GLOBEArcutis Biotherapeutics to Present at the Stifel 2020..
11/05/202016:21EDGARCurrent Report Filing (8-k)
11/05/202016:05GLOBEArcutis Announces Third Quarter 2020 Financial Results and..
11/04/202016:35EDGARStatement of Changes in Beneficial Ownership (4)
11/04/202016:34EDGARInitial Statement of Beneficial Ownership (3)
11/04/202016:34EDGARStatement of Changes in Beneficial Ownership (4)
11/04/202016:05GLOBEArcutis Announces Appointment of Terrie Curran to Board of..
11/02/202009:00GLOBEArcutis Biotherapeutics Presents New Positive Data from..
10/29/202021:07GLOBEArcutis Biotherapeutics to Present New Data from ARQ-151..
10/26/202009:00GLOBEArcutis Completes Enrollment in Phase 1/2b Study Evaluating ..
10/23/202013:28EDGARStatement of Changes in Beneficial Ownership (4)
10/06/202017:28EDGARStatement of Changes in Beneficial Ownership (4)
10/06/202017:24EDGARStatement of Changes in Beneficial Ownership (4)
10/06/202016:53EDGARCurrent Report Filing (8-k)
10/06/202016:05GLOBEArcutis Biotherapeutics Announces Closing of Public Offering..
10/06/202014:43EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
10/05/202016:17EDGARProspectus Filed Pursuant to Rule 424(b)(4) (424b4)
10/02/202006:04EDGARNotice of Effectiveness (effect)
10/01/202022:46GLOBEArcutis Biotherapeutics Announces Pricing of Public Offering..
9/29/202016:51GLOBEArcutis Biotherapeutics Announces Proposed Public Offering..
9/29/202016:20EDGARSecurities Registration Statement (s-1)
9/29/202016:02EDGARCurrent Report Filing (8-k)
9/29/202008:00GLOBEArcutis Announces Positive Topline Data from Phase 2..
9/18/202016:06EDGARCurrent Report Filing (8-k)
9/16/202017:58EDGARStatement of Changes in Beneficial Ownership (4)
9/16/202009:00GLOBEArcutis Completes Enrollment in DERMIS-1 and DERMIS-2..
9/15/202009:00GLOBEArcutis to Present at the Cantor Fitzgerald Global..
9/08/202009:00GLOBEArcutis Biotherapeutics to Accelerate ARQ-151 (Topical..
8/19/202017:49EDGARStatement of Changes in Beneficial Ownership (4)
8/11/202016:12EDGARQuarterly Report (10-q)
8/11/202016:08EDGARCurrent Report Filing (8-k)
8/11/202016:02GLOBEArcutis Announces Second Quarter 2020 Financial Results and..
8/10/202009:00GLOBEArcutis to Present at the Wedbush PacGrow Healthcare..
8/05/202017:13EDGARStatement of Changes in Beneficial Ownership (4)
8/05/202017:03EDGARStatement of Changes in Beneficial Ownership (4)
8/05/202017:02EDGARInitial Statement of Beneficial Ownership (3)
8/04/202009:00GLOBEBethany Dudek Joins Arcutis as Vice President of Quality
8/03/202009:00GLOBEThe Journal of Drugs in Dermatology Publishes Results from..
7/31/202016:06EDGARCurrent Report Filing (8-k)
7/31/202009:00GLOBEPreliminary Data from Long-Term Safety Study Support Chronic..
7/27/202009:00GLOBEArcutis Appoints Patrick Burnett, M.D., Ph.D., FAAD, as..
7/20/202009:00GLOBEArcutis Enrolls Last Patient in Phase 2b Clinical Trial..
7/15/202017:07GLOBEThe New England Journal of Medicine Publishes Results from..
7/13/202009:00GLOBEArcutis Initiates Patient Enrollment in the Phase 2b Portion..
6/22/202009:00GLOBEArcutis Enrolls Last Patient in Phase 2 Proof of Concept..
6/15/202015:16EDGARStatement of Changes in Beneficial Ownership (4)
6/10/202016:05GLOBEArcutis to Present at the Goldman Sachs 41st Annual Global..
See more news about this stock »


Your Recent History
NASDAQ
ARQT
Arcutis Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.